Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
Clover Health Investments, Corp. (Nasdaq: CLOV), a physician enablement technology company focused on Medicare, has announced its participation in two upcoming investor conferences. CFO Peter Kuipers will present at the 2024 KeyBanc Technology Leadership Forum on August 6, 2024, at 3:00 p.m. ET. Additionally, CEO Andrew Toy and CFO Peter Kuipers will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on August 14, 2024, at 2:00 p.m. ET.
Both presentations will be accessible via live webcast and replay on Clover Health's investor relations website. These conferences provide an opportunity for Clover Health to showcase its innovative approach to healthcare technology and engage with investors.
Clover Health Investments, Corp. (Nasdaq: CLOV), un'azienda tecnologica che abilita i medici e si concentra su Medicare, ha annunciato la sua partecipazione a due prossimi eventi per investitori. Il CFO Peter Kuipers presenterà al 2024 KeyBanc Technology Leadership Forum il 6 agosto 2024, alle 15:00 ET. Inoltre, il CEO Andrew Toy e il CFO Peter Kuipers parteciperanno a una chiacchierata informale al Canaccord Genuity 44th Annual Growth Conference il 14 agosto 2024, alle 14:00 ET.
Entrambe le presentazioni saranno disponibili tramite webcast dal vivo e in replica sul sito delle relazioni con gli investitori di Clover Health. Questi eventi offrono un'opportunità per Clover Health di esibire il suo approccio innovativo alla tecnologia sanitaria e interagire con gli investitori.
Clover Health Investments, Corp. (Nasdaq: CLOV), una empresa de tecnología que habilita a los médicos y se centra en Medicare, ha anunciado su participación en dos próximas conferencias para inversores. El CFO Peter Kuipers presentará en el 2024 KeyBanc Technology Leadership Forum el 6 de agosto de 2024, a las 3:00 p.m. ET. Además, el CEO Andrew Toy y el CFO Peter Kuipers participarán en una charla informal en el Canaccord Genuity 44th Annual Growth Conference el 14 de agosto de 2024, a las 2:00 p.m. ET.
Ambas presentaciones estarán disponibles a través de una transmisión en vivo y de una repetición en el sitio web de relaciones con inversores de Clover Health. Estas conferencias ofrecen una oportunidad para que Clover Health muestre su enfoque innovador en la tecnología de atención médica e interactúe con los inversores.
Clover Health Investments, Corp. (Nasdaq: CLOV), 메디케어에 중점을 두고 의사 지원 기술을 제공하는 회사는 두 개의 다가오는 투자자 회의에 참여한다고 발표했습니다. CFO 피터 쿠이퍼스는 2024년 8월 6일 오후 3시(ET) 2024 KeyBanc Technology Leadership Forum에서 발표할 예정입니다. 또한 CEO 앤드류 토이와 CFO 피터 쿠이퍼스는 2024년 8월 14일 오후 2시(ET) Canaccord Genuity 제44회 연례 성장 회의에 참여하여 화상 대화에 나설 예정입니다.
각 발표는 Clover Health의 투자자 관계 웹사이트를 통해 라이브 웹캐스트 및 다시보기로 제공됩니다. 이 회의는 Clover Health가 의료 기술에 대한 혁신적인 접근 방식을 선보이고 투자자와 소통할 수 있는 기회를 제공합니다.
Clover Health Investments, Corp. (Nasdaq: CLOV), une entreprise de technologie dédiée aux médecins et axée sur Medicare, a annoncé sa participation à deux prochaines conférences pour investisseurs. Le CFO Peter Kuipers présentera au 2024 KeyBanc Technology Leadership Forum le 6 août 2024 à 15h00 ET. De plus, le CEO Andrew Toy et le CFO Peter Kuipers participeront à une discussion informelle lors de la Canaccord Genuity 44th Annual Growth Conference le 14 août 2024 à 14h00 ET.
Les deux présentations seront accessibles via un webinaire en direct et en répétition sur le site Web des relations avec les investisseurs de Clover Health. Ces conférences offrent à Clover Health l'opportunité de présenter son approche innovante en matière de technologie de la santé et d'interagir avec les investisseurs.
Clover Health Investments, Corp. (Nasdaq: CLOV), ein Technologieunternehmen zur Unterstützung von Ärzten mit Fokus auf Medicare, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. CFO Peter Kuipers wird am 6. August 2024 um 15:00 Uhr ET auf dem 2024 KeyBanc Technology Leadership Forum präsentieren. Darüber hinaus werden CEO Andrew Toy und CFO Peter Kuipers an einem informellen Gespräch auf der Canaccord Genuity 44th Annual Growth Conference am 14. August 2024 um 14:00 Uhr ET teilnehmen.
Beide Präsentationen sind über einen Live-Webcast und eine Wiederholung auf der Investoren-Website von Clover Health zugänglich. Diese Konferenzen bieten Clover Health die Möglichkeit, ihren innovativen Ansatz in der Gesundheits-Technologie zu präsentieren und mit Investoren in Kontakt zu treten.
- None.
- None.
FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its participation in the following investor conferences:
- CFO, Peter Kuipers, will participate in a fireside chat presentation at the 2024 KeyBanc Technology Leadership Forum on Tuesday, August 6, 2024, at 3:00 p.m. Eastern Time.
- CEO, Andrew Toy, and CFO, Peter Kuipers, will participate in a fireside chat presentation at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024, at 2:00 p.m. Eastern Time.
A live webcast and reply of the fireside chat presentations will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
![](https://ml.globenewswire.com/media/OTA0MjJmNzItNWNlNC00NzRkLWJkOTItOTVlOGZkOThmNDYyLTExMDk5Njc=/tiny/Clover-Health-Investments-Corp.png)
FAQ
When is Clover Health (CLOV) participating in the 2024 KeyBanc Technology Leadership Forum?
Who will represent Clover Health (CLOV) at the Canaccord Genuity 44th Annual Growth Conference?
Where can investors access the webcast of Clover Health's (CLOV) conference presentations?